| |
| |
|
| Insider
Information: |
Jeffs Roger |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
131,223 |
|
|
Indirect Shares
|
73,445 |
|
|
| Direct
Value |
$9,184,422 |
|
|
|
Indirect Value
|
$10,471,277 |
|
|
| Total
Shares |
204,668 |
|
|
| Total
Value |
$19,655,699 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 29.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
United Therapeutics Corp |
UTHR |
President & Co-CEO, Di... |
2016-02-12 |
559 |
2016-02-12 |
26,533 |
Premium* |
|
|
Axsome Therapeutics, Inc. |
AXSM |
|
2024-03-15 |
120,756 |
2024-03-15 |
46,912 |
Premium* |
|
|
Dova Pharmaceuticals, Inc. |
DOVA |
Director |
2019-11-12 |
0 |
2017-07-05 |
0 |
Premium* |
|
|
Sangamo Biosciences Inc |
SGMO |
Director |
2018-09-07 |
9,908 |
2018-06-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXSM |
Axsome Therapeutics, Inc. |
|
– • – |
2024-03-15 |
4 |
AS |
$71.61 |
$168,062 |
D/D |
(2,347) |
120,756 |
0 |
% |
|
| AXSM |
Axsome Therapeutics, Inc. |
|
– • – |
2024-03-15 |
4 |
OE |
$29.91 |
$70,199 |
D/D |
2,347 |
123,103 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
|
– • – |
2024-03-14 |
4 |
OE |
$22.03 |
$719,787 |
D/D |
29,976 |
137,732 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
|
– • – |
2024-03-14 |
4 |
AS |
$69.70 |
$2,089,387 |
D/D |
(29,976) |
120,756 |
0 |
% |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2021-11-19 |
4 |
B |
$37.30 |
$147,350 |
D/D |
3,950 |
120,756 |
2.39 |
% |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2020-01-10 |
4 |
OE |
$4.95 |
$629,756 |
D/D |
60,186 |
116,806 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Director |
– • – |
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(66,993) |
0 |
0 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2019-07-03 |
4 |
OE |
$2.85 |
$172,178 |
D/D |
56,620 |
56,620 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Director |
– • – |
2019-07-01 |
4 |
AS |
$14.17 |
$18,534 |
D/D |
(1,308) |
66,993 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Director |
– • – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,901 |
68,301 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Director |
– • – |
2018-12-20 |
4 |
B |
$6.25 |
$7,306 |
D/D |
1,169 |
61,400 |
2.39 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Director |
– • – |
2018-12-19 |
4 |
B |
$6.22 |
$179,329 |
D/D |
28,831 |
60,231 |
2.39 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2018-09-07 |
4 |
B |
$13.56 |
$100,487 |
D/D |
7,408 |
9,908 |
2.39 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Director |
– • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| DOVA |
Dova Pharmaceuticals, Inc... |
Director |
– • – |
2017-07-05 |
4 |
B |
$17.00 |
$533,800 |
D/D |
31,400 |
31,400 |
2.39 |
- |
|
| AXSM |
Axsome Therapeutics, Inc. |
Director |
– • – |
2017-03-29 |
4 |
OE |
$3.67 |
$201,163 |
D/D |
42,538 |
46,912 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-02-12 |
4 |
D |
$126.56 |
$1,139,040 |
D/D |
(9,000) |
559 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-02-12 |
4 |
OE |
$65.80 |
$592,200 |
D/D |
9,000 |
9,559 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-01-27 |
4 |
OE |
$65.80 |
$197,400 |
D/D |
3,000 |
3,559 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-01-27 |
4 |
D |
$125.36 |
$376,080 |
D/D |
(3,000) |
559 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-01-22 |
4 |
D |
$129.44 |
$388,320 |
D/D |
(3,000) |
559 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-01-22 |
4 |
OE |
$65.80 |
$197,400 |
D/D |
3,000 |
3,559 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-01-20 |
4 |
D |
$128.61 |
$385,830 |
D/D |
(3,000) |
559 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-01-20 |
4 |
OE |
$65.80 |
$197,400 |
D/D |
3,000 |
3,559 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
President & Co-CEO |
• • – |
2016-01-15 |
4 |
OE |
$65.80 |
$197,400 |
D/D |
3,000 |
3,559 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
